Zobrazeno 1 - 7
of 7
pro vyhledávání: '"En Ying Tan"'
Autor:
Joshua Y. P. Yeo, Kevin Soon Hwee Teo, En Ying Tan, Clyve Yaow, H. Hariz, H. S. Lim, B. J. M. Ng, Y. H. L. Wong, Cantiriga Subramaniam, Andrew Makmur, Weiping Han, Mark Y. Y. Chan, Ching-Hui Sia, Mingxue Jing, Benjamin Y. Q. Tan, David K. K. Tang, Leonard Leong Litt Yeo
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Background and aimsEndovascular thrombectomy (EVT) is the current standard of care for large vessel occlusion (LVO) acute ischemic stroke (AIS); however, up to two-thirds of EVT patients have poor functional outcomes despite successful reperfusion. M
Externí odkaz:
https://doaj.org/article/16948ab889c04ab39977b08e3274b122
Autor:
Yeo, Joshua Y. P., Soon Hwee Teo, Kevin, En Ying Tan, Clyve Yaow, Hariz, H., Lim, H. S., Ng, B. J. M., Wong, Y. H. L., Subramaniam, Cantiriga, Makmur, Andrew, Weiping Han, Chan, Mark Y. Y., Ching-Hui Sia, Mingxue Jing, Tan, Benjamin Y. Q., Tang, David K. K., Leong Litt Yeo, Leonard
Publikováno v:
Frontiers in Neurology; 2024, p1-9, 9p
Autor:
Jie Ning Yong, Mark D. Muthiah, Daniel Huang, Cheng Han Ng, Raymond Wong, Mazen Noureddin, Nicholas Chew, Mohammad S. Siddiqui, Nicholas Syn, Eunice Xiang Xuan Tan, Wen Hui Lim, Darren Jun Hao Tan, Jieling Xiao, En Ying Tan
Publikováno v:
Liver Transplantation. 28:689-699
Background and aims The shift in the changing aetiology of cirrhosis requiring liver transplantation (LT) has resulted in an increasing prevalence of coronary artery disease (CAD) that can potentially impact post-liver transplant outcomes. This syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::001d5346b2bc3b3e989069ef67b269f3
https://doi.org/10.1002/lt.26331
https://doi.org/10.1002/lt.26331
Autor:
Darren Jun Hao Tan, Ryan Rui Yang Heng, Eunice Xiang Xuan Tan, Phoebe Wen Lin Tay, Vathsala Anantharaman, Yuki Ong, Daniel Huang, Cheng Han Ng, Vanessa Xin Yi Teo, Mark D. Muthiah, En Ying Tan
Publikováno v:
Transplant international : official journal of the European Society for Organ TransplantationREFERENCES. 34(12)
BACKGROUND AND AIMS Pre-liver transplant (LT) chronic kidney disease (CKD) has emerged as a leading cause of postoperative morbidity. We aimed to report the prevalence, associated risk factors and clinical outcomes in patients with pre-LT CKD. METHOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b6c52e4275bf90f920c605de5f532f9
https://pubmed.ncbi.nlm.nih.gov/34773291
https://pubmed.ncbi.nlm.nih.gov/34773291
Autor:
Raymond Wong, Nicholas Chew, Eunice Xiang Xuan Tan, Jie Ning Yong, Daniel Huang, Mohammad S. Siddiqui, Jieling Xiao, Mark D. Muthiah, Mazen Noureddin, Nicholas Syn, Darren Jun Hao Tan, Wen Hui Lim, En Ying Tan, Cheng Han Ng
Publikováno v:
Clinical Hepatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c92fd8639bc79d38b794e42e1bf816b0
https://doi.org/10.1136/gutjnl-2021-iddf.88
https://doi.org/10.1136/gutjnl-2021-iddf.88
Autor:
Jieling Xiao, Jonathan Zhi Kai Toh, Jie Ning Yong, Roger Foo, En Ying Tan, Jin Hean Koh, Cheng Han Ng, Phoebe Wen Lin Tay, Poay Huan Loh, Mark D. Muthiah, Mohammad S. Siddiqui, Yock Young Dan, Xin-Hui Pan, Eunice Xiang Xuan Tan, Nicholas Chew, Arun J. Sanyal
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 20(11)
Cardiovascular disease remains the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary heart disease (CHD) and NAFLD are cofounded by various cardiometabolic factors, particu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9aab52b91ca2354e5e03baf7d30fdd
https://pubmed.ncbi.nlm.nih.gov/34560278
https://pubmed.ncbi.nlm.nih.gov/34560278
Autor:
Guan Huei Lee, Seng Gee Lim, Boon Leng Kieron Lim, Sin Hui Melissa Chua, Mark D. Muthiah, En Ying Tan, Yock Young Dan, Daniel Q. Huang, Poh Seng Tan, Alfred Wei Chieh Kow, Glenn Kunnath Bonney
Publikováno v:
Hepatology international. 14(1)
Combination therapy with HBIG and NAs has reduced HBV recurrence post LT. Despite its efficacy, costs of HBIG remain prohibitive. With high-potency NAs, HBIG’s use has been questioned. We aim to evaluate the efficacy and safety of HBIG-free regimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14cdaafae5fabae32e27442e460dc638
https://pubmed.ncbi.nlm.nih.gov/31919678
https://pubmed.ncbi.nlm.nih.gov/31919678